SCHEMBL16115199

SCHEMBL16115199

[CH2]c1ccc(C(=O)c2c(Cl)cccc2Cl)cc1

nearest known ligand 0.50

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.50
DOT1L Q8TEK3 2/20 0.46
HPGD P15428 2/20 0.41
RORC P51449 5/20 0.40
FEN1 P39748 1/20 0.40
KMT2A Q03164 1/20 0.40
CYP3A4 P08684 2/20 0.39
CYP1A2 P05177 1/20 0.39
CYP2C9 P11712 1/20 0.39
CYP2C19 P33261 1/20 0.39
NPC1 O15118 1/20 0.39
GLA P06280 1/20 0.39
GAA P10253 4/20 0.39
LMNA P02545 1/20 0.38
MAPT P10636 1/20 0.38
SRD5A2 P31213 2/20 0.38
VCAM1 P19320 1/20 0.38
MAPK1 P28482 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11850279 0.83 SRD5A2 (0.56) ALDH1A1DOT1LHPGDGAASRD5A2
SCHEMBL611393 0.81 MAPK1 (0.59) ALDH1A1DOT1LHPGDKMT2AGAA
SCHEMBL1042856 0.80 ALDH1A1 (0.59) ALDH1A1DOT1LFEN1KMT2AGAA
SCHEMBL7503005 0.80 DOT1L (0.47) ALDH1A1DOT1LHPGDRORCFEN1
SCHEMBL9726458 0.79 ALDH1A1 (0.67) ALDH1A1DOT1LHPGDRORCFEN1
SCHEMBL7266220 0.79 ALDH1A1 (0.60) ALDH1A1DOT1LHPGDRORCNPC1
SCHEMBL609880 0.79 GAA (0.54) ALDH1A1DOT1LHPGDRORCKMT2A
SCHEMBL9615865 0.77 SRD5A2 (0.55) ALDH1A1HPGDKMT2ALMNAMAPT
SCHEMBL9050342 0.76 SRD5A2 (0.64) ALDH1A1HPGDKMT2ALMNAMAPT
SCHEMBL7264576 0.75 CES2 (0.52) ALDH1A1DOT1LHPGDRORCFEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160050930-A1 METHODS OF CONTROLLING NEONICOTINOID RESISTANT PESTS SYNGENTA LIMITED (UK) 2016-02-25 US disclosed
EP-2978316-A1 METHODS OF CONTROLLING NEONICOTINOID RESISTANT PESTS Syngenta Participations AG (CH) 2016-02-03 EP disclosed
WO-2014154488-A1 METHODS OF CONTROLLING NEONICOTINOID RESISTANT PESTS SYNGENTA PARTICIPATIONS AG (CH) 2014-10-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160050930-A1 METHODS OF CONTROLLING NEONICOTINOID RESISTANT PESTS DDT, CRY1, NISCH ALDH1A1 2576/4885DOT1L 2248/4885HPGD 1724/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.